Editorial, a. (2022). Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022). IMA PRESS LLC.
Chicago Style (17th ed.) CitationEditorial, article. Problems in the Treatment of Rheumatoid Arthritis and Prospects for the Use of an IL-1 Inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022). IMA PRESS LLC, 2022.
MLA (9th ed.) CitationEditorial, article. Problems in the Treatment of Rheumatoid Arthritis and Prospects for the Use of an IL-1 Inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022). IMA PRESS LLC, 2022.
Warning: These citations may not always be 100% accurate.